Laser Vaginal Rejuvenation in Singapore
Doctor-led assessment for selected vulvovaginal and vaginal-laxity concerns using non-ablative Er:YAG laser protocols such as IntimaLase where appropriate.
“Vaginal rejuvenation” is a marketing term, not a diagnosis. Vaginal laxity, genitourinary syndrome of menopause, pelvic-floor dysfunction, urinary leakage and sexual concerns have different causes and should not be treated as one condition.
This is an area where marketing has run considerably ahead of evidence, and where regulators internationally have warned about overstated claims. Our position is to describe honestly what is and is not supported, to insist on assessment before treatment, and to say plainly when a different pathway would serve you better.
At a glance
| What it is | Non-ablative Er:YAG laser delivered via an internal applicator, producing controlled mucosal heating rather than surface ablation |
|---|---|
| Proposed mechanism | A thermal response with collagen remodelling and changes in tissue hydration and elasticity |
| Discussed for | Self-reported vaginal laxity, selected genitourinary syndrome of menopause symptoms, and mild stress urinary leakage |
| Evidence status | Mixed. Short-term self-reported improvement is commonly reported; durability and objective measures vary between studies |
| Not a substitute for | Pelvic-floor physiotherapy, local hormonal treatment, continence assessment or surgical repair of prolapse |
| Anaesthesia | Usually none for the internal component. Topical anaesthetic may be used for external treatment |
| Downtime | Limited. Temporary warmth, irritation, discharge or light spotting can occur |
| Abstain from intercourse | Commonly for several days afterwards, as advised |
| Assessment first | Bulge, significant leakage, pain, unexplained bleeding or bowel symptoms need proper evaluation before any energy treatment |
| Where | Aquila Medical Center, 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914 |
What is non-ablative vaginal Er:YAG treatment?
Er:YAG energy can be delivered in specialised non-ablative pulse modes intended to heat mucosal tissue without conventional surface ablation. The proposed effect is a controlled thermal response with collagen remodelling and changes in tissue hydration and elasticity.
The distinction from facial resurfacing matters. The same wavelength used to ablate skin is here delivered in modified pulse sequences designed to deposit heat without removing tissue — because the vaginal mucosa is thin, moist and heals differently from facial skin, and ablating it would be neither appropriate nor safe.
Clinical outcomes depend on the indication, device protocol and patient selection. The evidence is mixed and should not be interpreted as proof that laser reliably treats every vaginal or urinary symptom.
On the evidence: studies in this field are frequently small, often lack a sham-controlled comparison group, and rely heavily on self-reported questionnaires. Where sham-controlled trials have been conducted, results have been less impressive than open-label studies suggested — a pattern worth knowing before committing to a course.
Concerns that may be discussed
Self-reported vaginal laxity
Some patients report improvement after energy-based treatment, but objective measures and durability vary between studies.
Menopause-related symptoms
Dryness, irritation or dyspareunia may reflect genitourinary syndrome of menopause. Vaginal moisturisers, lubricants and local hormonal treatment may have stronger established roles depending on medical suitability.
Stress urinary leakage
Laser has been studied, but pelvic-floor rehabilitation and established continence pathways remain important. Persistent leakage should be properly assessed rather than treated empirically.
Where hormones are unsuitable
For patients in whom local oestrogen is contraindicated or unwanted, energy-based options are sometimes discussed as an alternative after proper counselling.
External vulvar concerns
Some protocols address external tissue. These are separate indications from internal treatment and should be discussed specifically.
What it does not address
Prolapse, significant incontinence, obstetric sphincter injury, chronic pelvic pain and relationship or psychosexual factors are outside what a device can treat.
| Symptom | First-line consideration | Where laser might fit |
|---|---|---|
| Vaginal dryness after menopause | Moisturisers, lubricants and local oestrogen where suitable. | Considered where hormones are unsuitable or declined. |
| Pain with intercourse | Assessment of cause — atrophy, pelvic floor, scarring or other. | Only once the cause is established. |
| Leaking with cough or exercise | Pelvic-floor physiotherapy, which has good evidence. | Adjunct in mild cases after assessment, not first line. |
| Sensation of laxity | Pelvic-floor assessment and rehabilitation. | May be discussed for selected self-reported laxity. |
| A bulge or heaviness | Gynaecological assessment for prolapse. | Not appropriate — prolapse needs proper evaluation. |
| Recurrent urinary infections | Medical assessment and management. | Not a treatment for infection. |
| Bleeding after intercourse or postmenopause | Urgent gynaecological evaluation. | Never — this must be investigated first. |
Laser does not replace pelvic-floor assessment
Symptoms after childbirth can result from pelvic-floor muscle injury, prolapse, connective-tissue changes, scar pain, hormonal change or nerve injury. A laser procedure cannot correct all of these.
Women with a vaginal bulge, significant urinary leakage, faecal symptoms, pelvic pain or suspected prolapse may need pelvic-floor physiotherapy, gynaecological or urogynecological assessment rather than an energy procedure.
Pelvic-floor physiotherapy deserves to be named as the genuinely well-evidenced option here. Supervised pelvic-floor muscle training has solid trial support for stress urinary incontinence and is recommended as first-line treatment in major guidelines. It is less profitable than a device course and considerably better supported — which is exactly why a clinic should mention it first.
Laser compared with radiofrequency
| Non-ablative Er:YAG laser | Radiofrequency | |
|---|---|---|
| Energy delivery | Light absorbed by water in superficial mucosa, heating from the surface inward. | Electrical current generating heat through tissue resistance, more volumetrically. |
| Depth profile | More superficial, with heat conducting deeper. | Generally more diffuse bulk heating. |
| Sensation | Warmth, sometimes with a pulsing sensation. | Steady warmth, often described as comfortable. |
| Temperature control | Governed by pulse parameters. | Devices commonly include temperature monitoring during treatment. |
| Evidence | Mixed, with the same sham-control limitations across the field. | Mixed, with the same limitations. |
Neither has decisively better evidence than the other, and both share the same caveat: much of the published work is short-term and self-reported. The choice is generally made on comfort, protocol and clinician judgement rather than on one being demonstrably superior. Our RF page covers that modality in detail.
What to expect
Treatment is usually performed with an internal applicator and is designed to create controlled warming rather than conventional ablative resurfacing. Sensation varies and some patients experience warmth, irritation or temporary discharge afterward.
There is no universal number of sessions. Manufacturer protocols may suggest a course, but treatment should be guided by indication and response rather than by a fixed package.
Practically: the appointment is short, most patients describe warmth rather than pain, and no anaesthetic is usually required for the internal component. Treatment is scheduled outside menstruation, and a current cervical screening history is worth confirming beforehand — not because the laser affects it, but because any intimate assessment is a sensible prompt to check screening is up to date.
| Period | What is typical | What matters most |
|---|---|---|
| First 24 hours | Warmth, mild irritation, sometimes light discharge or spotting. | Avoid baths, pools, and follow the abstinence advice given. |
| Days 2–5 | Symptoms settle. Discharge may continue briefly. | Report anything painful, foul-smelling or heavier than spotting. |
| Weeks 2–6 | Any change in symptoms begins to be apparent. | Symptom diaries are more reliable than impression. |
| Across a course | Cumulative change if the treatment is going to help. | Honest review of whether symptoms actually improved. |
| Beyond 6–12 months | Effect may diminish; maintenance is often proposed. | Decide on evidence of benefit, not on a package schedule. |
Risks and when to postpone
Potential adverse effects include discomfort, burning, temporary bleeding or spotting, discharge, irritation, infection, persistent pain or worsening symptoms. Serious complications are uncommon but have been reported with vaginal energy devices in general.
Regulators internationally have issued safety communications about energy-based devices marketed for vaginal indications, citing both unsupported claims and reports of adverse events including pain, burning and scarring. That does not mean these treatments are never appropriate, but it does mean claims should be modest, consent should be genuinely informed, and anyone promising cure of incontinence or transformation of sexual function is overstating what is known.
Worsening pain after treatment deserves specific mention. Where a patient already has pain with intercourse or a pelvic pain condition, energy treatment can occasionally aggravate rather than help, which is another reason for establishing the cause before treating.
Do not proceed during pregnancy, active genital or urinary infection, unexplained bleeding, open wounds or soon after vaginal surgery. New bleeding, pain, a vaginal mass or abnormal discharge should be medically evaluated first.
Frequently asked questions
Does vaginal laser tighten the vagina?
Some patients report less laxity, but the degree of objective tissue change and durability varies. It should not be presented as equivalent to surgical repair.
Can laser cure stress urinary incontinence?
No guaranteed cure should be promised. Pelvic-floor muscle training has solid trial evidence and is recommended first line, so it should be discussed before any device.
Can laser improve sexual satisfaction?
Sexual function is multifactorial. A change in tissue sensation or dryness may help selected symptoms, but treatment should not promise improved sexual satisfaction.
Is there downtime?
Many patients have limited downtime, but temporary irritation, discharge or spotting can occur and activity restrictions may be advised.
How good is the evidence?
Mixed. Studies are frequently small, often lack sham controls and rely on self-reported questionnaires. Sham-controlled trials have generally shown less benefit than open-label studies suggested.
Does it hurt?
Most patients describe warmth rather than pain, and the internal component usually requires no anaesthetic. Sharp pain is not expected and should prompt stopping.
How is it different from RF treatment?
Laser heats via light absorbed in superficial mucosa; RF generates heat through tissue resistance more volumetrically. Neither has decisively better evidence, so choice rests on comfort, protocol and judgement.
Is this better than local oestrogen for dryness?
For genitourinary syndrome of menopause, local hormonal treatment has stronger established evidence where medically suitable. Laser is more reasonably considered where hormones are contraindicated or declined.
How many sessions will I need?
Protocols commonly suggest a short course, but treatment should follow indication and response rather than a fixed package purchased upfront.
How long do results last?
Effect may diminish over six to twelve months and maintenance is often proposed. That decision should rest on demonstrated benefit rather than a schedule.
Can I have it if I have a prolapse?
A bulge or sensation of heaviness needs gynaecological assessment first. Energy treatment is not a treatment for prolapse.
What if I have bleeding after intercourse or after menopause?
That requires urgent gynaecological evaluation before any cosmetic or energy treatment is considered. It must never be treated empirically.
Can it help recurrent urinary tract infections?
It is not a treatment for infection. Recurrent infections need medical assessment and management in their own right.
Should I abstain from intercourse afterwards?
Commonly for several days, as advised for your specific protocol. Baths and swimming are usually avoided initially too.
Can I have it during my period?
Treatment is scheduled outside menstruation. Any unexplained bleeding should be assessed rather than worked around.
Could it make my pain worse?
Occasionally, particularly where pain with intercourse or a pelvic pain condition already exists. This is another reason to establish the cause before treating.
Is it safe while breastfeeding?
Postpartum tissue and hormonal status are still changing, so elective treatment is generally deferred until things have stabilised and any pelvic-floor assessment is complete.
Should I try physiotherapy first?
For leakage, laxity sensation and most postpartum pelvic symptoms, yes. Supervised pelvic-floor muscle training is better evidenced than any energy device.
Is laser vaginal treatment claimable under MediSave or insurance in Singapore?
Treatment for cosmetic indications is generally not claimable. Where care addresses a diagnosed medical condition, check directly with your insurer.
Where is Aquila Medical Center?
Aquila Medical Center is at 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914, in the CBD, a short walk from Tanjong Pagar, Shenton Way and Telok Ayer MRT stations.
Selected references
- Pelvic Floor Dysfunction. StatPearls, NCBI Bookshelf.
- Genitourinary Syndrome of Menopause. StatPearls, NCBI Bookshelf.
- Energy-based devices for genitourinary syndrome of menopause: systematic review of clinical evidence.
- Sham-controlled trial of fractional laser for genitourinary syndrome of menopause.
- American College of Obstetricians and Gynecologists. Committee opinion on fractional laser treatment of vulvovaginal atrophy.
- US FDA. Safety communication on energy-based devices for vaginal rejuvenation.
This page is educational and does not replace an individual assessment. Suitability depends on diagnosis, symptoms and medical history, and several concerns discussed here are better addressed by pelvic-floor physiotherapy or specialist gynaecological care. Results vary and no outcome can be guaranteed. Content reviewed by the medical team at Aquila Medical Center, Singapore. Last reviewed: 26 August 2026.
Doctor-led intimate-health assessment
The first step is identifying whether the concern is laxity, menopausal tissue change, pelvic-floor dysfunction, prolapse or urinary incontinence. Laser is considered only where it fits that diagnosis.
Aquila Medical Center is located at 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914, a short walk from Tanjong Pagar, Shenton Way and Telok Ayer MRT stations. Where physiotherapy, hormonal treatment or specialist referral would serve you better, we will say so.